[{"NetIncomeLossConverted_1_FY_USD":-34204000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-100064000.0,"CommonStockSharesOutstanding_0_FY_shares":66599748.0,"StockholdersEquity_0_FY_USD":474676000.0,"EarningsPerShareBasic_1_FY_USD":-0.52,"EarningsPerShareBasic_4_FY_USD":-2.01,"RevenuesConverted_4_FY_USD":42983000.0,"RevenuesConverted_1_FY_USD":8751000.0,"Assets_0_FY_USD":567401000.0,"CommonStockSharesConverted_0_FY_shares":66599748.0,"NetIncomeLossConverted_4_FY_USD":-110378000.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210302"}]